Kim Nguyen

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

Daniel P. Petrylak, Ronald de Wit, Kim N. et al. · The Lancet · 2017 · 175 citations · Full text

Platinum-based Therapy, Urology, Metastatic Urothelial Carcinoma +8

Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy

Barry Trachtenberg, Darcy L. Velazquez, Adam Williams et al. · American Heart Journal · 2011 · 133 citations

Regenerative Medicine, Heart Failure Secondary, Heart Failure +10

A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer

Dana E. Rathkopf, Joel Picus, Arif Hussain et al. · Cancer Chemotherapy and Pharmacology · 2013 · 91 citations

Urology, Surgical Oncology, Oncology +6

Peroxisome proliferator–activated receptor δ limits the expansion of pathogenic Th cells during central nervous system autoimmunity

Shannon E. Dunn, R. Bhat, Daniel S. Straus et al. · The Journal of Experimental Medicine · 2010 · 91 citations · Full text

Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer

Christophe Massard, Kim Nguyen, Daniel Castellano et al. · European Journal of Cancer · 2017 · 90 citations

Urology, Abiraterone Acetate, Medicine +6